From

Institution

Field

Type

Open access only Cited by patents (Lens) Include non-Aachen papers (citing/cited)

Reset

Papers matching “hematologic malignancies” 41

Sort: Relevance Cited Newest Oldest Fwci Patents ⇩ CSV

Not finding it? Sign in to also search OpenAlex live.

Safety and Tolerability of AZD0466 As Monotherapy for Patients with Advanced Hematologic Malignancies. Results from a Phase I/II Trial
2023 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Cell death mechanisms and regulation

Shukaib Arslan, Giovanni Marconi, Giovanni Martinelli, Shaun A. Fleming, Antonio Curti, Shira Naomi Dinner, +19 more

5

citations
Treatment-specific risk of second malignancies in five-year survivors of diffuse large B-cell lymphoma.
2021 Journal of Clinical Oncology conference-abstract Medicine Multiple and Secondary Primary Cancers

Yvonne M.G. Geurts, Suzanne I.M. Neppelenbroek, Cynthia So‐Osman, Joost S.P. Vermaat, Dick Johan van Spronsen, Wouter J. Plattel, +14 more

1

citations
Poor Outcome of Patients with COVID-19 after CAR T-Cell Therapy for B-Cell Malignancies: Results from a Multicenter Study on Behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group
2021 Blood conference-abstract Medicine COVID-19 Clinical Research Studies Open access

Anne Mea Spanjaart, Per T Ljungman, Rafael de la Cámara, Gloria Tridello, Valentín Ortiz‐Maldonado, Álvaro Urbano-Ispizúa, +28 more

16

citations
Randomized Trial of Prophylactic Donor Lymphocyte Infusion with Positively Selected CD4+ T Cells after HLA-Identical Allogeneic Stem Cell Transplantation
2023 Blood conference-abstract Medicine Hematopoietic Stem Cell Transplantation Open access

Joost G.K. van der Hem, Peter van Balen, Sabrina A.J. Veld, Peter A. von dem Borne, Daniëlle van Lammeren, Tjeerd J.F. Snijders, +7 more

0

citations
HLA Class I Mismatches Reduce Survival after HCT in the Ptcy Era: A Study By the EBMT Cellular Therapy and Immunobiology Working Party
2023 Blood conference-abstract Medicine Hematopoietic Stem Cell Transplantation

Esteban Arrieta‐Bolaños, Edouard F. Bonneville, Marie Robin, Tobias Gedde‐Dahl, Urpu Salmenniemi, Nicolaus Martin Kröger, +20 more

2

citations
Abstract 4802: CAR-T cell therapy workflow for discovery and development
2025 Cancer Research conference-abstract Medicine CAR-T cell therapy research

David Cobeta Lopez, Benita Quist, Sara Compte-Sancerni, Sophie Vermond, Namrata Jayanth, Monika Hiller, +10 more

0

citations
Impact of Allogeneic Hematopoietic Cell Transplantation Post-Sars-Cov-2 Infection: A Retrospective Analysis By the German Cooperative Transplant Study Group
2024 Blood conference-abstract Medicine Hematopoietic Stem Cell Transplantation

Osama Ahmad, Jan Frederic Weller, Nicolaus Martin Kröger, Eva Wagner Drouet, David Nachbaur, Normann Steiner, +19 more

0

citations
Abstract 3232: In vitro cell based cytotoxicity and T cell activation assays to assess safety and efficacy of engineered T cell therapies
2020 Cancer Research conference-abstract Medicine CAR-T cell therapy research

Sanne L. Holt, Sophie Vermond, Monique Hazenoot, Jeroen Paardekooper Overman, Jamil Aarbiou, Jeroen DeGroot

0

citations
Overweight in the Dutch National Cohort of Long-Term Survivors of Childhood Cancer
2021 Blood conference-abstract Medicine Childhood Cancer Survivors' Quality of Life

Vincent G. Pluimakers, Jenneke E. van Atteveld, Demi T.C. de Winter, Marta F. Fiocco, Rutger A. J. Nievelstein, Dorine Bresters, +14 more

0

citations
STAT5-Activating Oncogenes Drive Oncostatin M Production Causing T Cell Exhaustion and Suppressive Myeloid Cell Recruitment
2024 Blood conference-abstract Medicine Cytokine Signaling Pathways and Interactions Open access

Michael P. Rassner, Tony Andreas Müller, Kirstyn Anne Crossley, Geoffroy Andrieux, Lena Jakob, Alina Müller-Rudorf, +13 more

1

citations
Clonal Hematopoiesis Is Common in Unrelated Stem Cell Donors but Has No Impact on Patient Outcome after Hematopoietic Stem Cell Transplantation
2023 Blood conference-abstract Medicine Hematopoietic Stem Cell Transplantation

Johannes Schetelig, Frédérik Damm, U. Günther, Henning Baldauf, Carina Rave, Linda Köster, +27 more

2

citations
ROP-ET: A Prospective Phase III Trial Investigating the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythemia Patients with Limited Treatment Options
2024 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment

Jean‐Jacques Kiladjian, Francisca Ferrer‐Marín, Haifa Kathrin Al‐Ali, Alberto Álvarez‐Larrán, Eloise Beggiato, Maria Bieniaszewska, +35 more

0

citations
Survey on fertility management and outcomes after cellular therapies, on behalf of the EBMT cellular therapy and immunobiology working party
2025 Blood conference-abstract Medicine Reproductive Biology and Fertility Open access

Giorgio Orofino, Victoria Grandage, Andrea Palasciano, Georg‐Nikolaus Franke, Lindsay George, Ron Ram, +20 more

0

citations
NFS-03. MEDULLOBLASTOMA IN CHILDREN WITH FANCONI ANEMIA: ASSOCIATION WITH FA-D1/FA-N, SHH TYPE AND POOR SURVIVAL INDEPENDENT OF TREATMENT STRATEGIES
2024 Neuro-Oncology conference-abstract Medicine Glioma Diagnosis and Treatment Open access

Marthe Sönksen, Denise Obrecht, Pablo Hernáiz Driever, Axel Sauerbrey, Norbert M. Graf, Udo Kontny, +11 more

0

citations
Eltrombopag Added to Standard Immunosuppressive Treatment Improves Long-Term Outcomes As Front-Line Therapy for Severe Aplastic Anemia: Final 2-Year Analysis of EBMT-Saawp Race Study
2024 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Blood disorders and treatments

Antonio Maria Risitano, Simona Iacobelli, Austin Gladston Kulasekararaj, Marleen van Os, Morag Griffin, Constantijn J.M. Halkes, +43 more

1

citations
An analysis of clonal dynamics in patients with indolent systemic mastocytosis treated with avapritinib in the pioneer study
2025 Blood conference-abstract Immunology and Microbiology Mast cells and histamine Open access

Jens Panse, Tsewang Tashi, Jason R. Gotlib, Mariana Castells, Iván Álvarez‐Twöse, Cem Akin, +12 more

0

citations
Liposomal melatonin targets mutant hematopoiesis and bone marrow remodeling in MPN
2025 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment

Siddharth Gupta, Alessandro Motta, Sara Elsafy, Julian Baumeister, Federica De Lorenzi, Shiva Khorshid, +17 more

0

citations
Allogeneic hematopoietic cell transplantation in dyskeratosis congenita: Short and long- term outcome of 183 consecutive patients transplanted at EBMT centers
2025 Blood conference-abstract Medicine Hematopoietic Stem Cell Transplantation

Fabiana Cacace, Filomena Pierri, Francesca Fioredda, Laura Van Hussen-Daenen, Dirk‐Jan Eikema, Joe Tuffnell, +29 more

1

citations
Distinct morphological features of malignant cells in large B-cell lymphoma identified by soft-segmentation in imaging-based spatial proteomics
2025 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Cell Image Analysis Techniques Open access

Troy Noordenbos, Marieke E. Ijsselsteijn, Noel de Miranda, Joost S.P. Vermaat, Mohammad Shahrokh Esfahani

0

citations
Talquetamab + Pomalidomide in Patients with Relapsed/Refractory Multiple Myeloma: Safety and Preliminary Efficacy Results from the Phase 1b MonumenTAL-2 Study
2023 Blood conference-abstract Medicine Multiple Myeloma Research and Treatments cited by 1 patent

Jeffrey Matous, Noa Biran, Aurore Perrot, Jesús G. Berdeja, Kathleen Anne Dorritie, Janine van Elssen, +10 more

45

citations
Euplagia-1: A Phase 1/2 Trial of GLPG5201, a Fresh Stem-like Early Memory CD19 CAR T-Cell Therapy with a 7-Day Vein-to-Vein Time, in Patients with Relapsed/Refractory CLL and RT
2024 Blood conference-abstract Medicine CAR-T cell therapy research Open access

Valentín Ortiz‐Maldonado, Núria Martínez‐Cibrián, Letícia Alserawan, Sergi Betriu, Ana Triguero, Sandra Blum, +8 more

5

citations
Molecular characterization of patients (pts) with myeloproliferative neoplasms treated with INCA033989 demonstrates selective targeting of CALR mutant hematopoietic cells
2025 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access

4

citations
The Use of MSCs in Steroid-Refractory Acute GvHD in Europe: A Survey from the EBMT Cellular Therapy & Immunobiology Working Party
2024 Blood conference-abstract Medicine Hematopoietic Stem Cell Transplantation Open access

Laura G.M. Daenen, Lotte E. van der Wagen, Edouard F. Bonneville, Lucía López‐Corral, Laimonas Griškevičius, Martin Bornhäuser, +9 more

0

citations
ZIP10 (SLC39A10) Is an Important Transport Protein in Acute Myeloid Leukemia
2024 Blood conference-abstract Nursing Trace Elements in Health

Benjamin Rolles, Nicolas Chatain, Richard Görg, Margherita Vieri, Nora Tillmann‐Tröster, Malvina Bourgeois, +13 more

0

citations
Interindividual HLA Evolutionary Divergence in Single HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation for Malignant Hematological Disorders: A Report on Behalf of the Cellular Therapy and Immunobiology Working Party of the EBMT
2023 Blood conference-abstract Medicine Hematopoietic Stem Cell Transplantation Open access

Simona Pagliuca, Jarl Mooyaart, Nicolaus Kröger, Jürgen Finke, Victoria T. Potter, Peter Dreger, +22 more

0

citations